Faculty


Co-Chairs:
Andreas du Bois, MD, PhD
Dr. Horst-Schmidt-Kliniken
Wiesbaden, Germany


Nicoletta Colombo, MD
University of Milan-Bicocc
European Institute of Oncology
Milan, Italy


Faculty:
Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire Hotel-Dieu
Paris, France


Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium


Stanley Kaye, MD
The Royal Marsden Hospital & Institute of Cancer Research
Sutton, United Kingdom


Agenda

Untitled Document
Friday, 13 November 2009
20.00-22.00 Welcome reception and buffet dinner
 
Saturday, 14 November 2009
08.30 Welcome, introduction and demographic questions
Andreas du Bois, MD, PhD
Nicoletta Colombo, MD
Bojana Pajk, MD
08.45

Interactive Case #1—Primary ovarian cancer: What’s optimal surgery?
Andreas du Bois, MD, PhD

09.30

Interactive Case #2—Initial systemic therapy for ovarian cancer
Nicoletta Colombo, MD
Commentary: Stanley Kaye, MD

10.10 Interactive Case #3—Recurrent ovarian cancer: Partially platinum–sensitive (Recurrence after 6-12 months)
Ignace Vergote, MD, PhD
10.45 Break
11.05 Interactive Case #4—Stage IIIB ovarian cancer: Recurrence >12 months following completion of induction chemotherapy
Eric Pujade-Lauraine, MD, PhD
11.35 Progress report on novel & targeted therapies for ovarian cancer
Stanley Kaye, MD
12.05 Interactive Case #5—Platinum resistant/refractory ovarian cancer: Optimizing quality of life
Eric Pujade-Lauraine, MD, PhD
12.35

Interactive Panel Discussion—The unanswered questions in ovarian cancer: Challenging the experts
Faculty Panel

13.05 Lunch
14.05 Interactive Case #6—Stage IIIC endometrial cancer: What’s the optimal strategy?
Nicoletta Colombo, MD
14.35 Interactive Case #7—Locally advanced stage (IIB) cervical carcinoma: Evaluating the options
Ignace Vergote, MD, PhD
15.05 Interactive Panel Discussion—Ask the experts
Faculty Panel
15.30

Concluding remarks
Andreas du Bois, MD, PhD
Nicoletta Colombo, MD
Bojana Pajk, MD

Program Slides

Print Materials

Support



Support for this activity has been provided by Schering-Plough.








Organizer

This meeting is a prIME Oncology activity.